93 related articles for article (PubMed ID: 16506893)
1. Ion channel gene therapy for smooth muscle disorders: relaxing smooth muscles to treat erectile dysfunction.
Schiff JD; Melman A
Assay Drug Dev Technol; 2006 Feb; 4(1):89-95. PubMed ID: 16506893
[TBL] [Abstract][Full Text] [Related]
2. Gene transfer with a vector expressing Maxi-K from a smooth muscle-specific promoter restores erectile function in the aging rat.
Melman A; Biggs G; Davies K; Zhao W; Tar MT; Christ GJ
Gene Ther; 2008 Mar; 15(5):364-70. PubMed ID: 18200069
[TBL] [Abstract][Full Text] [Related]
3. Plasmid-based gene transfer for treatment of erectile dysfunction and overactive bladder: results of a phase I trial.
Melman A; Bar-Chama N; McCullough A; Davies K; Christ G
Isr Med Assoc J; 2007 Mar; 9(3):143-6. PubMed ID: 17402321
[TBL] [Abstract][Full Text] [Related]
4. hMaxi-K gene transfer in males with erectile dysfunction: results of the first human trial.
Melman A; Bar-Chama N; McCullough A; Davies K; Christ G
Hum Gene Ther; 2006 Dec; 17(12):1165-76. PubMed ID: 17134370
[TBL] [Abstract][Full Text] [Related]
5. 4-Aryl-3-(hydroxyalkyl)quinolin-2-ones: novel maxi-K channel opening relaxants of corporal smooth muscle targeted for erectile dysfunction.
Hewawasam P; Fan W; Ding M; Flint K; Cook D; Goggins GD; Myers RA; Gribkoff VK; Boissard CG; Dworetzky SI; Starrett JE; Lodge NJ
J Med Chem; 2003 Jul; 46(14):2819-22. PubMed ID: 12825925
[TBL] [Abstract][Full Text] [Related]
6. Smooth-muscle-specific gene transfer with the human maxi-k channel improves erectile function and enhances sexual behavior in atherosclerotic cynomolgus monkeys.
Christ GJ; Andersson KE; Williams K; Zhao W; D'Agostino R; Kaplan J; Aboushwareb T; Yoo J; Calenda G; Davies KP; Sellers RS; Melman A
Eur Urol; 2009 Dec; 56(6):1055-66. PubMed ID: 19167152
[TBL] [Abstract][Full Text] [Related]
7. Editorial comment on: Smooth-muscle-specific gene transfer with the human maxi-K channel improves erectile function and enhances sexual behavior in atherosclerotic cynomolgus monkeys.
Hatzimouratidis K
Eur Urol; 2009 Dec; 56(6):1066. PubMed ID: 19167151
[No Abstract] [Full Text] [Related]
8. Gene therapy and erectile dysfunction: the current status.
Lau DH; Kommu SS; Siddiqui EJ; Thompson CS; Morgan RJ; Mikhailidis DP; Mumtaz FH
Asian J Androl; 2007 Jan; 9(1):8-15. PubMed ID: 16888683
[TBL] [Abstract][Full Text] [Related]
9. Gap junctions and ion channels: relevance to erectile dysfunction.
Christ GJ
Int J Impot Res; 2000 Oct; 12 Suppl 4():S15-25. PubMed ID: 11035382
[TBL] [Abstract][Full Text] [Related]
10. Can smooth muscle represent a useful target for the treatment of rapid ejaculation?
Abdel-Hamid IA
Drug Discov Today; 2005 Nov; 10(21):1459-66. PubMed ID: 16243266
[TBL] [Abstract][Full Text] [Related]
11. [Vardenafil for refractory erectile dysfunction: the latest advances].
Wang HY; Huang YF
Zhonghua Nan Ke Xue; 2009 Nov; 15(11):1035-8. PubMed ID: 20218319
[TBL] [Abstract][Full Text] [Related]
12. The therapeutic dilemma: how to use short-acting PDE5 inhibitor drugs.
Fabbri A; Aversa A
Int J Androl; 2005 Dec; 28 Suppl 2():69-73. PubMed ID: 16236069
[TBL] [Abstract][Full Text] [Related]
13. Gene transfer of the K(ATP) channel restores age-related erectile dysfunction in rats.
So I; Chae MR; Lee SW
BJU Int; 2007 Nov; 100(5):1154-60. PubMed ID: 17645416
[TBL] [Abstract][Full Text] [Related]
14. Adenosine signaling: good or bad in erectile function?
Wen J; Xia Y
Arterioscler Thromb Vasc Biol; 2012 Apr; 32(4):845-50. PubMed ID: 22423035
[TBL] [Abstract][Full Text] [Related]
15. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces the change of calcium mobilization via TRPC ion channels in cultured human corporal smooth muscle cells.
So I; Chae MR; Kim SJ; Lee SW
Int J Impot Res; 2005; 17(6):475-83. PubMed ID: 16034470
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo effects of vardenafil (a PDE-5 Inhibitor) on corpus cavernosal smooth muscle relaxation in diabetic rabbits.
Lau DH; Mumtaz FH; Mikhailidis DP; Thompson CS
Urol Int; 2009; 82(1):101-7. PubMed ID: 19172107
[TBL] [Abstract][Full Text] [Related]
17. Potassium channels and human corporeal smooth muscle cell tone: diabetes and relaxation of human corpus cavernosum smooth muscle by adenosine triphosphate sensitive potassium channel openers.
Venkateswarlu K; Giraldi A; Zhao W; Wang HZ; Melman A; Spektor M; Christ GJ
J Urol; 2002 Jul; 168(1):355-61. PubMed ID: 12050569
[TBL] [Abstract][Full Text] [Related]
18. Enhanced relaxation of diabetic rabbit cavernosal smooth muscle in response to nitric oxide: potential relevance to erectile dysfunction.
Sullivan ME; Mumtaz FH; Dashwood MR; Thompson CS; Naseem KM; Bruckdorfer KR; Mikhailidis DP; Morgan RJ
Int J Impot Res; 2002 Dec; 14(6):523-32. PubMed ID: 12494290
[TBL] [Abstract][Full Text] [Related]
19. Integrative erectile biology. The effects of age and disease on gap junctions and ion channels and their potential value to the treatment of erectile dysfunction.
Melman A; Christ GJ
Urol Clin North Am; 2001 May; 28(2):217-31, vii. PubMed ID: 11402576
[TBL] [Abstract][Full Text] [Related]
20. Chronic treatment with a type 5 phosphodiesterase inhibitor suppresses apoptosis of corporal smooth muscle by potentiating Akt signalling in a rat model of diabetic erectile dysfunction.
Park K; Ryu KS; Li WJ; Kim SW; Paick JS
Eur Urol; 2008 Jun; 53(6):1282-8. PubMed ID: 18243503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
